ATP Barcelona 2017

Summary Radiation Oncology is being revolutionized by new technologies and those are crucially dependent on imaging Prerequisites for changing concepts are a clinical need and the superiority of the new imaging to traditional methods and may vary significantly between tumors, tracers and clinical scenarios To seriously show patients benefit by the use of new imaging modalities in different clinical situations, clinical trials are mandatory Beyond target volume definition, other areas of the use of hybrid imaging in radiotherapy (response assessment, NT-monitoring …) are presently being investigated